Estramustine
Estramustine ( , , ) is an estrogen and cytostatic antineoplastic agent which was never marketed.
≈ 3 min read
Estramustine. encyclopegia.org, snapshot enwiki-001328996937. /a/estramustine
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Estramustine (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name, BANTooltip British Approved Name) is an estrogen and cytostatic antineoplastic agent which was never marketed.[1][2] It is a carbamate derivative of estradiol and acts in part as a prodrug of estradiol in the body.[1][2] Estramustine phosphate, the C17β phosphate ester of estramustine and a prodrug of estramustine, estromustine, estradiol, and estrone, is marketed and used in the treatment of prostate cancer.[1][2]
Synthesis
edit edit sourceEstramustine is a carbamate derivative of the natural hormone, estradiol. The amine (ClCH2CH2)2NH is treated with phosgene to give the acid chloride of normustine. This reacts with the phenolic hydroxyl group of estradiol in the presence of a base to give estramustine.[3][4]
See also
edit edit source- Estradiol mustard
- List of hormonal cytostatic antineoplastic agents
- List of estrogen esters § Estradiol esters
References
edit edit source- ^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 502–. ISBN 978-1-4757-2085-3. Wikipedia revision 1328996937, retrieved 2026-11-19
- ^ a b c Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 406–. ISBN 978-3-88763-075-1. Wikipedia revision 1328996937, retrieved 2026-11-19
- ^ Niculescu-Duvăz I, Cambanis A, Tărnăuceanu E (March 1967). "Potential anticancer agents. II. Urethan-type nitrogen mustards of some natural sex hormones". Journal of Medicinal Chemistry. 10 (2): 172–174. doi:10.1021/jm00314a009. PMID 6034059. Wikipedia revision 1328996937, retrieved 2026-11-19
- ^ Sk UH, Dixit D, Sen E (October 2013). "Comparative study of microtubule inhibitors--estramustine and natural podophyllotoxin conjugated PAMAM dendrimer on glioma cell proliferation". European Journal of Medicinal Chemistry. 68: 47–57. doi:10.1016/j.ejmech.2013.07.007. PMID 23954240. Wikipedia revision 1328996937, retrieved 2026-11-19
(M phase)
inhibitor
(S phase)
(CCNS)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Text derived from https://en.wikipedia.org/w/index.php?oldid=1328996937 under CC BY-SA 4.0; modifications have been made.